US Court Stops Overseas Drug Imports
A US court decided companies cannot bring Gilead's medicines from other countries, impacting health programs.
A big decision just came down from a US court. It changes how some medicines reach people here. The court ruled that companies cannot bring Gilead Sciences drugs into the country from overseas. This is a win for Gilead, a major drug maker.
Some programs help people get expensive medicines. They buy these drugs from other countries where they cost less. These are called alternative funding programs. This court decision hurts these programs. They must now stop importing certain Gilead medications.
This ruling means Gilead's power over its drugs in the US grows stronger. It makes it harder for some people to get these medicines at a lower price. This impacts health programs that try to save patients money. Patients relying on these programs may face higher costs for their treatment.
Source: CNBC
More from Biotech
